Perfil de la empresa · Healthcare

Stryker Corporation

SYK · EE. UU.
Bolsa
EE. UU.
País / Región
USA
Fecha de salida a bolsa
1 de febrero de 1988
Empleados
56.000
Precio actual
$307.8
En vivo · 18 de junio de 2026
Compra razonable
≤ $230
Entrada con margen de seguridad
Puntuación de crecimiento Baillie
49/100
Floja
Valor intrínseco · Rango en tres niveles Precio actual $307.8 En vivo · Entre el rango razonable y el optimista

Rango de valoración compuesto · conservador $170–$205 / razonable $230–$300 / optimista $310–$360. A $307.8, Entre el rango razonable y el optimista.

Al publicar $316.48 (25 de mayo de 2026)

Aún no hay análisis sobre este valor en tu idioma.

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Capitalización115,45 mil MUS$
Ingresos (TTM)25,27 mil MUS$
EBITDA6918 MUS$
Margen neto13,21 %
ROE15,2 %
PER (TTM)34,89
PER previsto20,08
PEG1,43
BPA8,63 US$
Rentabilidad por dividendo1,11 %
Rango de 52 semanas281,00 US$ – 401,86 US$
Precio objetivo de analistas386,80 US$
Recomendación de analistas4.1 / 5

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.